Risk assessment analysis, monitoring risk factor modification, and managing risk factors in patients with periodontal diseases, or those at high risk, are essential to successful treatment.
Calcium phosphate technologies may support the remineralization process, thereby helping to ensure the integrity of the tooth surface in the face of mineral loss.
Clinicians should be aware of current Food and Drug Administration-approved recommendations when determining the appropriate dose for individual patients.